ArticleClinical journal of the American Society of Nephrology : CJASN2016

Second-Line Agents for the Treatment of Type 2 Diabetes and Prevention of CKD.

Margaret K Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.